Idexx Laboratories (IDXX) Total Liabilities (2009 - 2026)

Idexx Laboratories (IDXX) has reported Total Liabilities for 18 consecutive years, with $1.8 billion the latest figure, recorded in Q1 2026.

• In Q1 2026, Total Liabilities rose 3.61% year-over-year to $1.8 billion; the TTM figure through Mar 2026 stood at $1.8 billion (up 3.61% YoY), while the FY2025 annual figure was $1.7 billion, up 2.78% from the prior year.
• Total Liabilities came in at $1.8 billion for Q1 2026 at Idexx Laboratories, up from $1.7 billion in the prior quarter.
• The five-year high for Total Liabilities was $2.2 billion in Q3 2022, with the low at $1.7 billion in Q4 2024.
• Average Total Liabilities over 5 years is $1.9 billion, with a median of $1.8 billion recorded in 2025.
• Across the five-year window, Total Liabilities surged 32.74% in 2022 and slipped 17.36% in 2023, its largest moves.
• Year by year, Total Liabilities stood at $2.1 billion in 2022, then fell by 16.96% to $1.8 billion in 2023, then decreased by 4.35% to $1.7 billion in 2024, then advanced by 2.78% to $1.7 billion in 2025, then climbed by 4.81% to $1.8 billion in 2026.
• According to Business Quant data, Total Liabilities over the past three periods registered $1.8 billion, $1.7 billion, and $1.8 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.